[
  {
    "title": "瑞康医药(002589.SZ)：拟收购乐康金岳9.6409%的股权",
    "href": "http://stock.jrj.com.cn/2022/12/15202037216279.shtml",
    "datetime": "2022-12-15 20:20:16",
    "code": "002589"
  },
  {
    "title": "瑞康医药(002589.SZ)：实控人质押3700万股",
    "href": "http://stock.jrj.com.cn/2022/12/07193037196049.shtml",
    "datetime": "2022-12-07 19:30:57",
    "code": "002589"
  },
  {
    "title": "瑞康医药(002589.SZ)：拟推2022年员工持股计划",
    "href": "http://stock.jrj.com.cn/2022/12/06222537193372.shtml",
    "datetime": "2022-12-06 22:25:24",
    "code": "002589"
  },
  {
    "title": "瑞康医药(002589.SZ)：员工持股计划出售完毕",
    "href": "http://stock.jrj.com.cn/2022/11/20171037152468.shtml",
    "datetime": "2022-11-20 17:10:17",
    "code": "002589"
  },
  {
    "title": "瑞康医药(002589.SZ)：实控人韩旭、张仁华合计解质3810.2118万股",
    "href": "http://stock.jrj.com.cn/2022/11/16190537144507.shtml",
    "datetime": "2022-11-16 19:05:01",
    "code": "002589"
  },
  {
    "title": "瑞康医药(002589.SZ)：实控人韩旭、张仁华合计解质7800万股",
    "href": "http://stock.jrj.com.cn/2022/11/08190237121479.shtml",
    "datetime": "2022-11-08 19:02:41",
    "code": "002589"
  },
  {
    "title": "瑞康医药(002589.SZ)第三季度净利209.41万元 同比下降78.93%",
    "href": "http://stock.jrj.com.cn/2022/10/30203037097856.shtml",
    "datetime": "2022-10-30 20:30:51",
    "code": "002589"
  },
  {
    "title": "瑞康医药(002589.SZ)上半年净利5899.09万元，同比下降48.95%",
    "href": "http://stock.jrj.com.cn/2022/08/29223636949556.shtml",
    "datetime": "2022-08-29 22:36:43",
    "code": "002589"
  },
  {
    "title": "瑞康医药(002589.SZ)：实控人韩旭质押2600万股",
    "href": "http://stock.jrj.com.cn/2022/08/05191436874781.shtml",
    "datetime": "2022-08-05 19:14:07",
    "code": "002589"
  },
  {
    "title": "【龙虎榜】瑞康医药7月14日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/07/14180136811998.shtml",
    "datetime": "2022-07-14 18:01:45",
    "code": "002589"
  },
  {
    "title": "【龙虎榜】瑞康医药7月13日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/07/13180236808056.shtml",
    "datetime": "2022-07-13 18:02:54",
    "code": "002589"
  },
  {
    "title": "【龙虎榜】瑞康医药7月12日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/07/12180236804076.shtml",
    "datetime": "2022-07-12 18:02:33",
    "code": "002589"
  },
  {
    "title": "“拉萨天团”扎堆入驻 瑞康医药股价四连板",
    "href": "http://stock.jrj.com.cn/2022/07/12091136802336.shtml",
    "datetime": "2022-07-12 09:11:16",
    "code": "002589"
  },
  {
    "title": "【龙虎榜】瑞康医药7月11日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/07/11180236799593.shtml",
    "datetime": "2022-07-11 18:02:31",
    "code": "002589"
  },
  {
    "title": "重药控股、瑞康医药等多只商业医药股涨停 全球首个新冠预防药Evusheld在博鳌开打",
    "href": "http://stock.jrj.com.cn/2022/07/11102336798065.shtml",
    "datetime": "2022-07-11 10:23:51",
    "code": "002589"
  },
  {
    "title": "【龙虎榜】瑞康医药7月8日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/07/08180136795180.shtml",
    "datetime": "2022-07-08 18:01:51",
    "code": "002589"
  },
  {
    "title": "瑞康医药(002589.SZ)：未与阿斯利康签署任何关于Evusheld(恩适得)中国大陆代理的协议",
    "href": "http://stock.jrj.com.cn/2022/07/07190136791836.shtml",
    "datetime": "2022-07-07 19:01:06",
    "code": "002589"
  },
  {
    "title": "瑞康医药拟修改公司章程 第五大股东长城国融投出弃权票",
    "href": "http://stock.jrj.com.cn/2022/05/24113436673203.shtml",
    "datetime": "2022-05-24 11:34:23",
    "code": "002589"
  },
  {
    "title": "瑞康医药(002589.SZ)：实控人韩旭质押1900万股",
    "href": "http://stock.jrj.com.cn/2022/05/05202136571578.shtml",
    "datetime": "2022-05-05 20:21:35",
    "code": "002589"
  },
  {
    "title": "【龙虎榜】瑞康医药4月11日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/04/11180236305451.shtml",
    "datetime": "2022-04-11 18:02:27",
    "code": "002589"
  },
  {
    "title": "【龙虎榜】瑞康医药4月8日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/04/08180236273256.shtml",
    "datetime": "2022-04-08 18:02:42",
    "code": "002589"
  },
  {
    "title": "【龙虎榜】瑞康医药4月7日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/04/07180136268636.shtml",
    "datetime": "2022-04-07 18:01:22",
    "code": "002589"
  },
  {
    "title": "瑞康医药上演“天地板”",
    "href": "http://stock.jrj.com.cn/2022/04/07144836267691.shtml",
    "datetime": "2022-04-07 14:48:49",
    "code": "002589"
  },
  {
    "title": "【龙虎榜】瑞康医药4月1日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/04/01180336248007.shtml",
    "datetime": "2022-04-01 18:03:30",
    "code": "002589"
  },
  {
    "title": "瑞康医药(002589.SZ)连续第二日涨停 与阿斯利康携手在全国范围内拓展阿斯利康产品",
    "href": "http://stock.jrj.com.cn/2022/04/01093636245261.shtml",
    "datetime": "2022-04-01 09:36:24",
    "code": "002589"
  },
  {
    "title": "瑞康医药(002589.SZ)：实控人张仁华自2021年11月25日起累计减持2.05%股份",
    "href": "http://stock.jrj.com.cn/2022/03/29215536159488.shtml",
    "datetime": "2022-03-29 21:55:13",
    "code": "002589"
  },
  {
    "title": "瑞康医药高溢价回购资产疑为实控人之子救急 疯狂并购商誉减值26亿仍有7亿悬顶",
    "href": "http://stock.jrj.com.cn/2022/03/01074534503231.shtml",
    "datetime": "2022-03-01 07:45:34",
    "code": "002589"
  },
  {
    "title": "瑞康医药(002589.SZ)：实控人韩旭、张仁华合计质押1.1亿股",
    "href": "http://stock.jrj.com.cn/2022/02/22203334435906.shtml",
    "datetime": "2022-02-22 20:33:31",
    "code": "002589"
  },
  {
    "title": "瑞康医药：拟2.3亿元收购国慧大健康约38.4%股权 有助于增强公司盈利能力",
    "href": "http://stock.jrj.com.cn/2022/02/17202834383180.shtml",
    "datetime": "2022-02-17 20:28:56",
    "code": "002589"
  },
  {
    "title": "瑞康医药(002589.SZ)：拟以约2.3亿元收购天津国慧大健康38.4%股权",
    "href": "http://stock.jrj.com.cn/2022/02/17200534383043.shtml",
    "datetime": "2022-02-17 20:05:27",
    "code": "002589"
  },
  {
    "title": "【龙虎榜】瑞康医药1月13日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/13180334154816.shtml",
    "datetime": "2022-01-13 18:03:15",
    "code": "002589"
  },
  {
    "title": "瑞康医药(002589.SZ)：实控人韩旭解质5775万股",
    "href": "http://stock.jrj.com.cn/2022/01/10204034142783.shtml",
    "datetime": "2022-01-10 20:40:09",
    "code": "002589"
  },
  {
    "title": "瑞康医药2021年半年度净利1.16亿元 同比净利减少24.72%",
    "href": "http://stock.jrj.com.cn/2021/08/30215833355555.shtml",
    "datetime": "2021-08-30 21:58:26",
    "code": "002589"
  },
  {
    "title": "瑞康医药(002589.SZ)：实控人韩旭质押2700万股",
    "href": "http://stock.jrj.com.cn/2021/08/07160333216488.shtml",
    "datetime": "2021-08-07 16:03:52",
    "code": "002589"
  },
  {
    "title": "瑞康医药：实际控制人所持2320.955万股解除质押",
    "href": "http://stock.jrj.com.cn/2021/07/16100033106288.shtml",
    "datetime": "2021-07-16 10:00:19",
    "code": "002589"
  },
  {
    "title": "瑞康医药(002589.SZ)：实控人解除质押2320.96万股",
    "href": "http://stock.jrj.com.cn/2021/07/16083333105506.shtml",
    "datetime": "2021-07-16 08:33:12",
    "code": "002589"
  },
  {
    "title": "瑞康医药(002589.SZ)2020年度权益分派10派0.18元 股权登记日为6月22日",
    "href": "http://stock.jrj.com.cn/2021/06/16192132941951.shtml",
    "datetime": "2021-06-16 19:21:47",
    "code": "002589"
  },
  {
    "title": "瑞康医药：威海衡健医院管理有限公司和内蒙古包氏蒙医国际整骨医院主营业务为中医诊疗服务",
    "href": "http://stock.jrj.com.cn/2021/05/13141032747972.shtml",
    "datetime": "2021-05-13 14:10:47",
    "code": "002589"
  },
  {
    "title": "瑞康医药：公司目前经营的烟台凤翔山庄养老服务中心是一个医养结合的项目",
    "href": "http://stock.jrj.com.cn/2021/05/13134532747817.shtml",
    "datetime": "2021-05-13 13:45:54",
    "code": "002589"
  },
  {
    "title": "瑞康医药(002589.SZ)：一季度净利8165.78万元 同比下降13.03%",
    "href": "http://stock.jrj.com.cn/2021/04/30085532484525.shtml",
    "datetime": "2021-04-30 08:55:29",
    "code": "002589"
  },
  {
    "title": "瑞康医药并购后遗症：向子公司提起诉讼 短期偿债能力遭问询",
    "href": "http://stock.jrj.com.cn/2021/04/21100132414718.shtml",
    "datetime": "2021-04-21 10:01:00",
    "code": "002589"
  },
  {
    "title": "瑞康医药年报收问询函 深交所问206亿元流动负债",
    "href": "http://stock.jrj.com.cn/2021/04/20173832410809.shtml",
    "datetime": "2021-04-20 17:38:00",
    "code": "002589"
  },
  {
    "title": "瑞康医药常州公司遭江苏警告 200盒过期药品放合格区",
    "href": "http://stock.jrj.com.cn/2021/04/01164232263538.shtml",
    "datetime": "2021-04-01 16:42:00",
    "code": "002589"
  },
  {
    "title": "瑞康医药2020年净利2.61亿扭亏为盈：董事长韩旭薪酬43.69万",
    "href": "http://stock.jrj.com.cn/2021/03/31194832257833.shtml",
    "datetime": "2021-03-31 19:48:43",
    "code": "002589"
  },
  {
    "title": "瑞康医药子公司违法遭罚71万 未按照产品技术要求生产",
    "href": "http://stock.jrj.com.cn/2021/03/30180932248892.shtml",
    "datetime": "2021-03-30 18:09:55",
    "code": "002589"
  },
  {
    "title": "必须说清楚！向子公司“要钱”得靠起诉？ 瑞康医药的并购“苦果”还在消化",
    "href": "http://stock.jrj.com.cn/2021/03/19082632161900.shtml",
    "datetime": "2021-03-19 08:26:00",
    "code": "002589"
  },
  {
    "title": "瑞康医药(002589.SZ)：实控人张仁华解除质押8740万股",
    "href": "http://stock.jrj.com.cn/2021/02/21174231999442.shtml",
    "datetime": "2021-02-21 17:42:57",
    "code": "002589"
  },
  {
    "title": "瑞康医药副总经理秦晓华辞职 持有公司52.62万股股票",
    "href": "http://stock.jrj.com.cn/2021/01/28094731799758.shtml",
    "datetime": "2021-01-28 09:47:56",
    "code": "002589"
  },
  {
    "title": "瑞康医药2020年预计净利3亿-4亿扭亏为盈 商誉净值大幅减少",
    "href": "http://stock.jrj.com.cn/2021/01/26213931780668.shtml",
    "datetime": "2021-01-26 21:39:31",
    "code": "002589"
  },
  {
    "title": "瑞康医药(002589.SZ)：拟开展即期余额不超30亿元票据池业务",
    "href": "http://stock.jrj.com.cn/2020/12/11161931465182.shtml",
    "datetime": "2020-12-11 16:19:50",
    "code": "002589"
  },
  {
    "title": "甘肃飞检22家药企全被要求整改 含瑞康医药旗下公司",
    "href": "http://stock.jrj.com.cn/2020/11/26173931353707.shtml",
    "datetime": "2020-11-26 17:39:00",
    "code": "002589"
  },
  {
    "title": "瑞康医药前三季净利下滑近70% 公司否认13亿元定增“涉嫌利益输送”",
    "href": "http://stock.jrj.com.cn/2020/11/13065631271608.shtml",
    "datetime": "2020-11-13 06:56:11",
    "code": "002589"
  },
  {
    "title": "瑞康医药(002589.SZ)：拟以8100万元参与投设无锡阿斯利康中金创业投资合伙企业",
    "href": "http://stock.jrj.com.cn/2020/11/01165131184302.shtml",
    "datetime": "2020-11-01 16:51:15",
    "code": "002589"
  },
  {
    "title": "瑞康医药(002589.SZ)：非公开发行股票申请获中证监受理",
    "href": "http://stock.jrj.com.cn/2020/11/01164831184303.shtml",
    "datetime": "2020-11-01 16:48:44",
    "code": "002589"
  },
  {
    "title": "瑞康医药2020年前三季度净利3.09亿下滑46.65% 销售额下降",
    "href": "http://stock.jrj.com.cn/2020/11/01135631183641.shtml",
    "datetime": "2020-11-01 13:56:57",
    "code": "002589"
  },
  {
    "title": "瑞康医药：2020年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/10/30232031177568.shtml",
    "datetime": "2020-10-30 23:20:00",
    "code": "002589"
  },
  {
    "title": "瑞康医药：与阿斯利康在“诊疗一体化”等领域达成战略合作",
    "href": "http://stock.jrj.com.cn/2020/10/19195831085447.shtml",
    "datetime": "2020-10-19 19:58:10",
    "code": "002589"
  },
  {
    "title": "瑞康医药2020年上半年净利2.1亿下滑45.1% 受疫情影响公司业务发展速度下降",
    "href": "http://stock.jrj.com.cn/2020/08/28203830616427.shtml",
    "datetime": "2020-08-28 20:38:58",
    "code": "002589"
  },
  {
    "title": "瑞康医药上半年营收超126亿元 二季度实现净利环比大幅向好",
    "href": "http://stock.jrj.com.cn/2020/08/28100630612072.shtml",
    "datetime": "2020-08-28 10:06:32",
    "code": "002589"
  },
  {
    "title": "瑞康医药去年亏损9亿未业绩预告 总经理尹世强遭批评",
    "href": "http://stock.jrj.com.cn/2020/08/13161330491910.shtml",
    "datetime": "2020-08-13 16:13:00",
    "code": "002589"
  },
  {
    "title": "瑞康医药4名股东合计减持3009.41万股 套现约1.71亿元",
    "href": "http://stock.jrj.com.cn/2020/08/05113830430808.shtml",
    "datetime": "2020-08-05 11:38:47",
    "code": "002589"
  },
  {
    "title": "瑞康医药实控人之子低价“独吞”13亿元定增",
    "href": "http://stock.jrj.com.cn/2020/08/04212530426233.shtml",
    "datetime": "2020-08-04 21:25:54",
    "code": "002589"
  },
  {
    "title": "瑞康医药拟定增募资不超13亿元",
    "href": "http://stock.jrj.com.cn/2020/08/03213130415495.shtml",
    "datetime": "2020-08-03 21:31:51",
    "code": "002589"
  },
  {
    "title": "瑞康医药：拟定增募资不超13亿元",
    "href": "http://stock.jrj.com.cn/2020/08/03203430415187.shtml",
    "datetime": "2020-08-03 20:34:55",
    "code": "002589"
  },
  {
    "title": "瑞康医药首家互联网医院正式上线运营",
    "href": "http://stock.jrj.com.cn/2020/06/08192729873739.shtml",
    "datetime": "2020-06-08 19:27:00",
    "code": "002589"
  },
  {
    "title": "瑞康医药第一季净利9560.51万同比减少49.65% 受疫情影响所致",
    "href": "http://stock.jrj.com.cn/2020/05/04114129528649.shtml",
    "datetime": "2020-05-04 11:41:18",
    "code": "002589"
  },
  {
    "title": "瑞康医药2019年亏损9.28亿 较上年同期由盈转亏",
    "href": "http://stock.jrj.com.cn/2020/04/30121829429811.shtml",
    "datetime": "2020-04-30 12:18:56",
    "code": "002589"
  },
  {
    "title": "瑞康医药：商誉计提影响2019年利润 未来两年进行内生整合",
    "href": "http://stock.jrj.com.cn/2020/04/29080429414586.shtml",
    "datetime": "2020-04-29 08:04:00",
    "code": "002589"
  },
  {
    "title": "瑞康医药旗下吉祥天区块链医药健康服务平台上线",
    "href": "http://stock.jrj.com.cn/2020/03/24102329092813.shtml",
    "datetime": "2020-03-24 10:23:00",
    "code": "002589"
  },
  {
    "title": "雪上加霜！瑞康医药实控人近九成股份质押 疯狂并购“埋雷”",
    "href": "http://stock.jrj.com.cn/2020/03/24082329091746.shtml",
    "datetime": "2020-03-24 08:23:00",
    "code": "002589"
  },
  {
    "title": "瑞康医药：再捐赠500万元医疗设备 累计捐赠已超4600万元",
    "href": "http://stock.jrj.com.cn/2020/03/04145428951657.shtml",
    "datetime": "2020-03-04 14:54:00",
    "code": "002589"
  },
  {
    "title": "大肆并购“后遗症”爆发 瑞康医药回复问询各式“甩锅”",
    "href": "http://stock.jrj.com.cn/2020/03/03073328941884.shtml",
    "datetime": "2020-03-03 07:33:28",
    "code": "002589"
  },
  {
    "title": "商誉减值业绩亏损 瑞康医药表示90余个资产组22.4亿商誉减值合理",
    "href": "http://stock.jrj.com.cn/2020/03/02193128935912.shtml",
    "datetime": "2020-03-02 19:31:45",
    "code": "002589"
  },
  {
    "title": "瑞康医药及多家子公司被纳入全国疫情防控重点保障企业名单",
    "href": "http://stock.jrj.com.cn/2020/02/27143028906204.shtml",
    "datetime": "2020-02-27 14:30:00",
    "code": "002589"
  },
  {
    "title": "瑞康医药拟为全资及控股子公司向银行申请综合授信提供担保 金额不超12亿",
    "href": "http://stock.jrj.com.cn/2020/02/22092928874789.shtml",
    "datetime": "2020-02-22 09:29:16",
    "code": "002589"
  },
  {
    "title": "瑞康医药2019年预计亏损10亿 对90余个资产组计提商誉减值准备约22.4亿",
    "href": "http://stock.jrj.com.cn/2020/02/21210828873539.shtml",
    "datetime": "2020-02-21 21:08:40",
    "code": "002589"
  },
  {
    "title": "瑞康医药2019年净利润亏损10.21亿元 计提大额商誉减值原因及合理性引关注",
    "href": "http://stock.jrj.com.cn/2020/02/21203928873409.shtml",
    "datetime": "2020-02-21 20:39:00",
    "code": "002589"
  },
  {
    "title": "瑞康医药：预计计提商誉减值准备约22.4亿元",
    "href": "http://stock.jrj.com.cn/2020/02/21200728873248.shtml",
    "datetime": "2020-02-21 20:07:28",
    "code": "002589"
  },
  {
    "title": "瑞康医药：2019年度预计对90余个资产组计提商誉减值准备金额约为22.4亿元",
    "href": "http://stock.jrj.com.cn/2020/02/21192928873050.shtml",
    "datetime": "2020-02-21 19:29:05",
    "code": "002589"
  },
  {
    "title": "瑞康医药亏损超10亿 深交所发函询问商誉减值金额是否合理",
    "href": "http://stock.jrj.com.cn/2020/02/21181228872520.shtml",
    "datetime": "2020-02-21 18:12:28",
    "code": "002589"
  },
  {
    "title": "瑞康医药2019年预计亏损10.21亿元 商誉减值22.4亿元",
    "href": "http://stock.jrj.com.cn/2020/02/21094428869251.shtml",
    "datetime": "2020-02-21 09:44:12",
    "code": "002589"
  },
  {
    "title": "瑞康医药：疫情发生后得到多家银行资金支持",
    "href": "http://stock.jrj.com.cn/2020/02/18205528850489.shtml",
    "datetime": "2020-02-18 20:55:00",
    "code": "002589"
  },
  {
    "title": "瑞康医药：目前公司有阿比朵尔在售",
    "href": "http://stock.jrj.com.cn/2020/02/05095828774179.shtml",
    "datetime": "2020-02-05 09:58:20",
    "code": "002589"
  },
  {
    "title": "瑞康医药：目前有阿比朵尔在售 库存充足",
    "href": "http://stock.jrj.com.cn/2020/02/05090028773762.shtml",
    "datetime": "2020-02-05 09:00:00",
    "code": "002589"
  },
  {
    "title": "瑞康医药再度捐赠1000万元医疗设备及试剂驰援烟台抗疫一线",
    "href": "http://stock.jrj.com.cn/2020/02/02184928749012.shtml",
    "datetime": "2020-02-02 18:49:00",
    "code": "002589"
  },
  {
    "title": "瑞康医药再捐赠1000万元医疗设备及试剂",
    "href": "http://stock.jrj.com.cn/2020/02/02181528748904.shtml",
    "datetime": "2020-02-02 18:15:00",
    "code": "002589"
  },
  {
    "title": "驰援武汉 瑞康医药再度捐赠价值500万医疗设备和诊断试剂",
    "href": "http://stock.jrj.com.cn/2020/01/30125828742811.shtml",
    "datetime": "2020-01-30 12:58:00",
    "code": "002589"
  },
  {
    "title": "瑞康医药再捐赠500万元医疗设备及试剂",
    "href": "http://stock.jrj.com.cn/2020/01/30125128742800.shtml",
    "datetime": "2020-01-30 12:51:00",
    "code": "002589"
  },
  {
    "title": "瑞康医药股东汇添富基金拟减持不超2%股份",
    "href": "http://stock.jrj.com.cn/2020/01/06204628633012.shtml",
    "datetime": "2020-01-06 20:46:33",
    "code": "002589"
  },
  {
    "title": "瑞康医药：汇添富基金拟减持不超2%股份",
    "href": "http://stock.jrj.com.cn/2020/01/06173928631952.shtml",
    "datetime": "2020-01-06 17:39:07",
    "code": "002589"
  },
  {
    "title": "瑞康医药：汇添富基金拟减持不超2%公司股份",
    "href": "http://stock.jrj.com.cn/2020/01/06171428631801.shtml",
    "datetime": "2020-01-06 17:14:00",
    "code": "002589"
  },
  {
    "title": "携手浙商银行推出区块链健康服务平台 瑞康医药欲“掘金”业务数据库？",
    "href": "http://stock.jrj.com.cn/2019/11/20214028428774.shtml",
    "datetime": "2019-11-20 21:40:38",
    "code": "002589"
  },
  {
    "title": "瑞康医药4名股东合计减持3009万股 套现约2.32亿元",
    "href": "http://stock.jrj.com.cn/2019/11/20175528427857.shtml",
    "datetime": "2019-11-20 17:55:50",
    "code": "002589"
  },
  {
    "title": "关于为“天风证券-招商财富瑞康医药供应链金融1期资产支持专项计划”提供转让服务的公告",
    "href": "http://stock.jrj.com.cn/2019/11/19223028421542.shtml",
    "datetime": "2019-11-19 22:30:00",
    "code": "002589"
  },
  {
    "title": "瑞康医药第三季度盈利1.95亿元 同比减少23%",
    "href": "http://stock.jrj.com.cn/2019/10/31133828332889.shtml",
    "datetime": "2019-10-31 13:38:27",
    "code": "002589"
  },
  {
    "title": "过半货币资金受限 瑞康医药将12亿募集资金补充流动性",
    "href": "http://stock.jrj.com.cn/2019/09/24083228171194.shtml",
    "datetime": "2019-09-24 08:32:00",
    "code": "002589"
  },
  {
    "title": "过半货币资金受限 瑞康医药将12亿募集资金补充流动性",
    "href": "http://stock.jrj.com.cn/2019/09/24080628171198.shtml",
    "datetime": "2019-09-24 08:06:00",
    "code": "002589"
  },
  {
    "title": "瑞康医药终止部分募投项目 结余资金永久补充流动资金",
    "href": "http://stock.jrj.com.cn/invest/2019/09/23090328166029.shtml",
    "datetime": "2019-09-23 09:03:00",
    "code": "002589"
  },
  {
    "title": "【瑞康医药】大幅拉升4.23% 股价创近2个月新高",
    "href": "http://stock.jrj.com.cn/2019/09/12133028126874.shtml",
    "datetime": "2019-09-12 13:30:22",
    "code": "002589"
  },
  {
    "title": "【瑞康医药】大幅拉升8.08% 股价创历史新高",
    "href": "http://stock.jrj.com.cn/2019/09/06140628100316.shtml",
    "datetime": "2019-09-06 14:06:46",
    "code": "002589"
  },
  {
    "title": "【瑞康医药】大幅拉升4.74% 股价创历史新高",
    "href": "http://stock.jrj.com.cn/2019/09/06130628100169.shtml",
    "datetime": "2019-09-06 13:06:15",
    "code": "002589"
  },
  {
    "title": "瑞康医药上半年稳健增长 全新战略蓝图预计10月底出炉",
    "href": "http://stock.jrj.com.cn/2019/08/28231628051956.shtml",
    "datetime": "2019-08-28 23:16:51",
    "code": "002589"
  },
  {
    "title": "瑞康医药2019年上半年净利3.83亿 不断加大市场营销力度",
    "href": "http://stock.jrj.com.cn/2019/08/28220628051562.shtml",
    "datetime": "2019-08-28 22:06:45",
    "code": "002589"
  },
  {
    "title": "瑞康医药：拟参与设立天津瑞康海河医疗基金",
    "href": "http://stock.jrj.com.cn/2019/06/03220427659449.shtml",
    "datetime": "2019-06-03 22:04:47",
    "code": "002589"
  },
  {
    "title": "瑞康医药：合计持股8%的股东拟减持不超2%股份",
    "href": "http://stock.jrj.com.cn/2019/05/09195127549364.shtml",
    "datetime": "2019-05-09 19:51:55",
    "code": "002589"
  },
  {
    "title": "瑞康医药：股东汇添富基金拟减持不超2%",
    "href": "http://stock.jrj.com.cn/2019/05/09195027549363.shtml",
    "datetime": "2019-05-09 19:50:00",
    "code": "002589"
  },
  {
    "title": "瑞康医药一季度净利1.9亿同比下滑32% 现金流量净额1.05亿",
    "href": "http://stock.jrj.com.cn/2019/05/06063327526680.shtml",
    "datetime": "2019-05-06 06:33:11",
    "code": "002589"
  },
  {
    "title": "瑞康医药去年营收339亿元 同比增长46% 董事长韩旭薪酬44万元",
    "href": "http://stock.jrj.com.cn/2019/05/05084727522915.shtml",
    "datetime": "2019-05-05 08:47:11",
    "code": "002589"
  },
  {
    "title": "医疗器械板块发力 瑞康医药2018年营收增超四成",
    "href": "http://stock.jrj.com.cn/2019/04/29232827509842.shtml",
    "datetime": "2019-04-29 23:28:11",
    "code": "002589"
  },
  {
    "title": "瑞康医药2018年营收339.19亿元 连续4年超40%增长",
    "href": "http://stock.jrj.com.cn/2019/04/29214027509349.shtml",
    "datetime": "2019-04-29 21:40:00",
    "code": "002589"
  },
  {
    "title": "瑞康医药：与江苏毅达签署战略合作协议",
    "href": "http://stock.jrj.com.cn/2019/03/26201627243266.shtml",
    "datetime": "2019-03-26 20:16:27",
    "code": "002589"
  },
  {
    "title": "瑞康医药6名股东合计增持321万股 耗资3663.02万元",
    "href": "http://stock.jrj.com.cn/2019/02/13221327039979.shtml",
    "datetime": "2019-02-13 22:13:49",
    "code": "002589"
  },
  {
    "title": "瑞康医药6名高管、员工完成3663万元增持：浮亏40% 年薪15万",
    "href": "http://stock.jrj.com.cn/2019/02/13133427038171.shtml",
    "datetime": "2019-02-13 13:34:51",
    "code": "002589"
  },
  {
    "title": "瑞康医药下调2018年盈利预期 预盈金额减少超1008万",
    "href": "http://stock.jrj.com.cn/2019/01/31144127008096.shtml",
    "datetime": "2019-01-31 14:41:35",
    "code": "002589"
  },
  {
    "title": "瑞康医药：汇添富基金拟减持不超2%股份",
    "href": "http://stock.jrj.com.cn/2019/01/10181626886266.shtml",
    "datetime": "2019-01-10 18:16:31",
    "code": "002589"
  },
  {
    "title": "瑞康医药拟最高溢价66%实施回购",
    "href": "http://stock.jrj.com.cn/2018/12/14003726737344.shtml",
    "datetime": "2018-12-14 00:37:49",
    "code": "002589"
  },
  {
    "title": "瑞康医药：拟2亿元至4亿元回购股份",
    "href": "http://stock.jrj.com.cn/2018/12/12211526346972.shtml",
    "datetime": "2018-12-12 21:15:21",
    "code": "002589"
  },
  {
    "title": "瑞康医药：实控人提议公司回购2亿元至4亿元股份",
    "href": "http://stock.jrj.com.cn/2018/12/12205526342074.shtml",
    "datetime": "2018-12-12 20:55:00",
    "code": "002589"
  },
  {
    "title": "瑞康医药：2018年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/10/30005025274364.shtml",
    "datetime": "2018-10-30 00:50:00",
    "code": "002589"
  },
  {
    "title": "瑞康医药携手民生银行 开拓医药供应链金融新模式",
    "href": "http://stock.jrj.com.cn/2018/10/26152725264343.shtml",
    "datetime": "2018-10-26 15:27:33",
    "code": "002589"
  },
  {
    "title": "瑞康医药：上半年净利5.8亿元 同比增长13%",
    "href": "http://stock.jrj.com.cn/hotstock/2018/08/24075924994757.shtml",
    "datetime": "2018-08-24 07:59:57",
    "code": "002589"
  },
  {
    "title": "瑞康医药：拟开展供应链应付账款资产证券化项目",
    "href": "http://stock.jrj.com.cn/hotstock/2018/08/24075924994801.shtml",
    "datetime": "2018-08-24 07:59:57",
    "code": "002589"
  },
  {
    "title": "瑞康医药：2018年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/08/23234024993662.shtml",
    "datetime": "2018-08-23 23:40:00",
    "code": "002589"
  },
  {
    "title": "瑞康医药：上半年净利5.8亿元 同比增13%",
    "href": "http://stock.jrj.com.cn/2018/08/23202524992805.shtml",
    "datetime": "2018-08-23 20:25:00",
    "code": "002589"
  },
  {
    "title": "瑞康医药董事、高管和核心骨干拟合计增持不低于3600万元",
    "href": "http://stock.jrj.com.cn/2018/08/06212824912302.shtml",
    "datetime": "2018-08-06 21:28:29",
    "code": "002589"
  },
  {
    "title": "瑞康医药：董事、高管和核心骨干拟增持股份",
    "href": "http://stock.jrj.com.cn/2018/08/06204024912182.shtml",
    "datetime": "2018-08-06 20:40:00",
    "code": "002589"
  },
  {
    "title": "瑞康医药总裁张仁华：把握“两票制”整合机会 谋求器械流通头部地位",
    "href": "http://stock.jrj.com.cn/2018/06/20095024703678.shtml",
    "datetime": "2018-06-20 09:50:00",
    "code": "002589"
  },
  {
    "title": "瑞康医药业绩增势强劲 直销模式和器械配送看点足",
    "href": "http://stock.jrj.com.cn/2018/04/26235524459466.shtml",
    "datetime": "2018-04-26 23:55:41",
    "code": "002589"
  },
  {
    "title": "瑞康医药去年净利10.08亿 布局先进医疗器械研发生产",
    "href": "http://stock.jrj.com.cn/2018/04/26115824455424.shtml",
    "datetime": "2018-04-26 11:58:00",
    "code": "002589"
  },
  {
    "title": "瑞康医药：2018年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/04/25232024452356.shtml",
    "datetime": "2018-04-25 23:20:00",
    "code": "002589"
  },
  {
    "title": "瑞康医药商誉9个月翻倍存减值隐忧",
    "href": "http://stock.jrj.com.cn/2018/02/26072724150761.shtml",
    "datetime": "2018-02-26 07:27:50",
    "code": "002589"
  },
  {
    "title": "瑞康医药：实控人拟10.23亿元转让5%公司股份给招商慧泽",
    "href": "http://stock.jrj.com.cn/2018/02/25201624149299.shtml",
    "datetime": "2018-02-25 20:16:00",
    "code": "002589"
  },
  {
    "title": "瑞康医药:实控人向招商慧泽协议转让7523万股公司股份",
    "href": "http://stock.jrj.com.cn/2018/02/25172624148967.shtml",
    "datetime": "2018-02-25 17:26:31",
    "code": "002589"
  },
  {
    "title": "瑞康医药2017年净利润同比增七成",
    "href": "http://stock.jrj.com.cn/2018/02/01093224043032.shtml",
    "datetime": "2018-02-01 09:32:00",
    "code": "002589"
  },
  {
    "title": "瑞康医药：股东拟斥资不低于2亿元增持",
    "href": "http://stock.jrj.com.cn/2017/12/25210023848735.shtml",
    "datetime": "2017-12-25 21:00:00",
    "code": "002589"
  },
  {
    "title": "海欣医药8326万元引入上市公司瑞康医药",
    "href": "http://stock.jrj.com.cn/2017/12/20220723826911.shtml",
    "datetime": "2017-12-20 22:07:58",
    "code": "002589"
  },
  {
    "title": "[鲁抗医药]鲁抗医药与瑞康医药举行战略合作洽谈会",
    "href": "http://stock.jrj.com.cn/2017/12/13000031601318.shtml",
    "datetime": "2017-12-13 00:00:00",
    "code": "002589"
  },
  {
    "title": "瑞康医药：2017年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2017/08/27182023008095.shtml",
    "datetime": "2017-08-27 18:20:00",
    "code": "002589"
  },
  {
    "title": "山西证券：上半年净利同比增约三成 固定收益业务收益",
    "href": "http://stock.jrj.com.cn/hotstock/2017/07/28080022810017.shtml",
    "datetime": "2017-07-28 08:00:00",
    "code": "002589"
  },
  {
    "title": "瑞康医药2016年净利近6亿元 同比增150%",
    "href": "http://stock.jrj.com.cn/2017/01/25194122012526.shtml",
    "datetime": "2017-01-25 19:41:31",
    "code": "002589"
  },
  {
    "title": "[互动]瑞康医药：今年拟完成20个省控股公司收购",
    "href": "http://stock.jrj.com.cn/2016/05/06090520922963.shtml",
    "datetime": "2016-05-06 09:05:06",
    "code": "002589"
  },
  {
    "title": "瑞康医药：证监会中止审查公司非公开发行方案 短期回避风险",
    "href": "http://stock.jrj.com.cn/2016/02/23215120597757.shtml",
    "datetime": "2016-02-23 21:51:51",
    "code": "002589"
  },
  {
    "title": "机构博弈 瑞康医药打开跌停板",
    "href": "http://stock.jrj.com.cn/2015/10/15051719928242.shtml",
    "datetime": "2015-10-15 05:17:24",
    "code": "002589"
  },
  {
    "title": "瑞康医药:深改组会议审议通过公立医院改革方案",
    "href": "http://stock.jrj.com.cn/2015/04/10110319083807.shtml",
    "datetime": "2015-04-10 11:03:30",
    "code": "002589"
  },
  {
    "title": "瑞康医药：业绩保持快速增长 全年预增25%~35%",
    "href": "http://stock.jrj.com.cn/2014/10/27152618241920.shtml",
    "datetime": "2014-10-27 15:26:00",
    "code": "002589"
  },
  {
    "title": "瑞康医药12定增 唯一机构汇添富认购8亿力捧",
    "href": "http://stock.jrj.com.cn/2014/07/14075817592000.shtml",
    "datetime": "2014-07-14 07:58:33",
    "code": "002589"
  },
  {
    "title": "瑞康医药拟定增募12亿补血",
    "href": "http://stock.jrj.com.cn/2014/07/03015217533582.shtml",
    "datetime": "2014-07-03 01:52:10",
    "code": "002589"
  },
  {
    "title": "瑞康医药已建有药品电子商务平台",
    "href": "http://stock.jrj.com.cn/2014/02/19161916704552.shtml",
    "datetime": "2014-02-19 16:19:00",
    "code": "002589"
  },
  {
    "title": "瑞康医药2013年净利润增三成",
    "href": "http://stock.jrj.com.cn/2014/02/14070816666262.shtml",
    "datetime": "2014-02-14 07:08:24",
    "code": "002589"
  },
  {
    "title": "瑞康医药烟台募投项目基本完工 仓储紧张有望缓解",
    "href": "http://stock.jrj.com.cn/2013/10/18134515986628.shtml",
    "datetime": "2013-10-18 13:45:32",
    "code": "002589"
  },
  {
    "title": "瑞康医药：器械业务跨入爆发期 维持“买入”评级",
    "href": "http://stock.jrj.com.cn/hotstock/2013/07/17112715545073.shtml",
    "datetime": "2013-07-17 11:27:58",
    "code": "002589"
  },
  {
    "title": "瑞康医药定增32%净利润率遭质疑",
    "href": "http://stock.jrj.com.cn/2012/09/20151114418321.shtml",
    "datetime": "2012-09-20 15:11:57",
    "code": "002589"
  },
  {
    "title": "贵州茅台预收款骤降30亿 姚凯推瑞康医药超32%",
    "href": "http://stock.jrj.com.cn/hotstock/2012/08/13061814110974.shtml",
    "datetime": "2012-08-13 06:18:48",
    "code": "002589"
  },
  {
    "title": "两医药公司齐推定增方案",
    "href": "http://stock.jrj.com.cn/2012/07/23010513876295.shtml",
    "datetime": "2012-07-23 01:05:01",
    "code": "002589"
  },
  {
    "title": "瑞康医药募资6.2亿加码医疗器械配送",
    "href": "http://stock.jrj.com.cn/2012/07/20212313869744.shtml",
    "datetime": "2012-07-20 21:23:03",
    "code": "002589"
  },
  {
    "title": "瑞康医药拟审议定增事项",
    "href": "http://stock.jrj.com.cn/2012/07/20033513856837.shtml",
    "datetime": "2012-07-20 03:35:00",
    "code": "002589"
  },
  {
    "title": "瑞康医药：区域医药商业龙头 增长确定",
    "href": "http://stock.jrj.com.cn/hotstock/2012/02/20165612292572.shtml",
    "datetime": "2012-02-20 16:56:41",
    "code": "002589"
  },
  {
    "title": "瑞康医药：高盈利水平依旧 新增长点凸显",
    "href": "http://stock.jrj.com.cn/hotstock/2012/02/03170512167256.shtml",
    "datetime": "2012-02-03 17:05:04",
    "code": "002589"
  },
  {
    "title": "瑞康医药去年盈利8389万元 同比增长35%",
    "href": "http://stock.jrj.com.cn/2012/02/01204812148346.shtml",
    "datetime": "2012-02-01 20:48:25",
    "code": "002589"
  },
  {
    "title": "瑞康医药领涨周五新股 史丹利首日收跌11%",
    "href": "http://stock.jrj.com.cn/ipo/2011/06/10162910176496.shtml",
    "datetime": "2011-06-10 16:29:00",
    "code": "002589"
  },
  {
    "title": "瑞康医药今日登陆中小板",
    "href": "http://stock.jrj.com.cn/2011/06/10105510172608.shtml",
    "datetime": "2011-06-10 10:55:36",
    "code": "002589"
  },
  {
    "title": "瑞康医药今登中小板 直销业务将做大做强",
    "href": "http://stock.jrj.com.cn/sme/2011/06/10095010171170.shtml",
    "datetime": "2011-06-10 09:50:43",
    "code": "002589"
  },
  {
    "title": "瑞康医药中签率为3.119% 冻结资金125亿元",
    "href": "http://stock.jrj.com.cn/ipo/2011/06/02193410121077.shtml",
    "datetime": "2011-06-02 19:34:54",
    "code": "002589"
  },
  {
    "title": "瑞康医药：“广覆盖、深挖掘”的医药商业开拓者",
    "href": "http://stock.jrj.com.cn/hotstock/2011/06/02123810117711.shtml",
    "datetime": "2011-06-02 12:38:57",
    "code": "002589"
  },
  {
    "title": "瑞康医药：快长的山东医药流通龙头",
    "href": "http://stock.jrj.com.cn/ipo/2011/06/02114510117287.shtml",
    "datetime": "2011-06-02 11:45:17",
    "code": "002589"
  },
  {
    "title": "瑞康医药拟发不超2380万股 6月1日实施申购",
    "href": "http://stock.jrj.com.cn/ipo/2011/05/23215810032747.shtml",
    "datetime": "2011-05-23 21:58:56",
    "code": "002589"
  },
  {
    "title": "瑞康医药和蓝科石化首发18日上会",
    "href": "http://stock.jrj.com.cn/ipo/2011/04/1420509735074.shtml",
    "datetime": "2011-04-14 20:50:21",
    "code": "002589"
  }
]